Vektor Medical, a medical technology company transforming cardiac arrhythmia care, today announced that Ascension St. Vincent's has enrolled the first patient in the VITAL-EP study. The study is ...
Background. The prognostic significance of a second programmed ventricular stimulation (PVS) at electrophysiology study (EPS), when the first PVS is negative for inducible ventricular tachycardia (VT) ...
Healio and Cardiology Today present the most-read articles on arrhythmia disorders published in 2019. In no particular order, Healio readers were most interested in results of the Apple Heart Study, ...
Many arrhythmias have no clear cause; these idiopathic cases arise without identifiable triggers, while for others, the ...
SAN FRANCISCO--(BUSINESS WIRE)--Vektor Medical today announced positive results from its “Vektor vMap™ Clinical Validation Study” evaluating the accuracy of cardiac mapping with vMap™. The study ...
First Patient Enrolled at Ascension St. Vincent’s in Jacksonville, Florida Vektor Medical, a medical technology company transforming cardiac arrhythmia care, today announced that Ascension St. Vincent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results